154 related articles for article (PubMed ID: 8683233)
21. Clinical evaluation of the new tumor marker TAG-72.
Guadagni F; Roselli M; Ferroni P; Amato T; Colcher D; Greiner JW; Schlom J
Anticancer Res; 1991; 11(4):1389-94. PubMed ID: 1746895
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of surface antigen expression on human breast carcinoma cells by recombinant human interferons.
Tran R; Hand PH; Greiner JW; Pestka S; Schlom J
J Interferon Res; 1988 Feb; 8(1):75-88. PubMed ID: 3130426
[TBL] [Abstract][Full Text] [Related]
23. CA 72-4 radioimmunoassay for the detection of the TAG-72 carcinoma-associated antigen in serum of patients.
Gero EJ; Colcher D; Ferroni P; Melsheimer R; Giani S; Schlom J; Kaplan P
J Clin Lab Anal; 1989; 3(6):360-9. PubMed ID: 2614571
[TBL] [Abstract][Full Text] [Related]
24. Increased surface expression and shedding of tumor associated antigens by human breast carcinoma cells treated with recombinant human interferons or phorbol ester tumor promoters.
Leon JA; Mesa-Tejada R; Gutierrez MC; Estabrook A; Greiner JW; Schlom J; Fisher PB
Anticancer Res; 1989; 9(6):1639-47. PubMed ID: 2516715
[TBL] [Abstract][Full Text] [Related]
25. A phase I trial of interferon-alpha-2a plus cyclophosphamide, vincristine, prednisone, and doxorubicin.
Schiller JH; Hawkins MJ; O'Connell MJ; Sielaff K; Borden EC
J Biol Response Mod; 1989 Jun; 8(3):252-61. PubMed ID: 2746297
[TBL] [Abstract][Full Text] [Related]
26. Phase I trial of high-dose bolus interleukin-2 and interferon alfa-2a in patients with metastatic malignancy.
Budd GT; Murthy S; Finke J; Sergi J; Gibson V; Medendorp S; Barna B; Boyett J; Bukowski RM
J Clin Oncol; 1992 May; 10(5):804-9. PubMed ID: 1569452
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the interferon-gamma-mediated regulation of tumor-associated antigens expressed by human gastric carcinoma cells.
Shimada S; Ogawa M; Schlom J; Greiner JW
In Vivo; 1993; 7(1):1-8. PubMed ID: 8504201
[TBL] [Abstract][Full Text] [Related]
28. Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer.
Hege KM; Bergsland EK; Fisher GA; Nemunaitis JJ; Warren RS; McArthur JG; Lin AA; Schlom J; June CH; Sherwin SA
J Immunother Cancer; 2017; 5():22. PubMed ID: 28344808
[TBL] [Abstract][Full Text] [Related]
29. Biological response modifiers as adjuvants in monoclonal antibody-based treatment (review).
Guadagni F; Roselli M; Nieroda C; Dansky-Ullmann G; Schlom J; Greiner JW
In Vivo; 1993; 7(6B):591-9. PubMed ID: 8193280
[TBL] [Abstract][Full Text] [Related]
30. Modulation of carcinoembryonic antigen messenger RNA levels in human colon carcinoma cells by recombinant human gamma-interferon.
Kantor J; Tran R; Greiner J; Pestka S; Fisher PB; Shively JE; Schlom J
Cancer Res; 1989 May; 49(10):2651-5. PubMed ID: 2496918
[TBL] [Abstract][Full Text] [Related]
31. Effect of recombinant alpha-interferon on pharmacokinetics, biodistribution, toxicity, and efficacy of 131I-labeled monoclonal antibody CC49 in breast cancer: a phase II trial.
Macey DJ; Grant EJ; Kasi L; Rosenblum MG; Zhang HZ; Katz RL; Rieger PT; LeBherz D; South M; Greiner JW; Schlom J; Podoloff DA; Murray JL
Clin Cancer Res; 1997 Sep; 3(9):1547-55. PubMed ID: 9815842
[TBL] [Abstract][Full Text] [Related]
32. Interferons can upregulate the expression of the tumor associated antigen G250-MN/CA IX, a potential target for (radio)immunotherapy of renal cell carcinoma.
Brouwers AH; Frielink C; Oosterwijk E; Oyen WJ; Corstens FH; Boerman OC
Cancer Biother Radiopharm; 2003 Aug; 18(4):539-47. PubMed ID: 14503948
[TBL] [Abstract][Full Text] [Related]
33. TAG-72 (CA 72-4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancer.
Guadagni F; Roselli M; Cosimelli M; Mannella E; Tedesco M; Cavaliere F; Grassi A; Abbolito MR; Greiner JW; Schlom J
Cancer; 1993 Oct; 72(7):2098-106. PubMed ID: 8374868
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the absolute bioavailability of pegylated interferon alfa-2a after subcutaneous administration to healthy male volunteers: an open-label, randomized, parallel-group study.
Brennan BJ; Xu ZX; Grippo JF
Clin Ther; 2012 Sep; 34(9):1883-91. PubMed ID: 22858176
[TBL] [Abstract][Full Text] [Related]
35. Differential effects of recombinant human leukocyte interferons on cell surface antigen expression.
Greiner JW; Fisher PB; Pestka S; Schlom J
Cancer Res; 1986 Oct; 46(10):4984-90. PubMed ID: 2944575
[TBL] [Abstract][Full Text] [Related]
36. Characterization of gastric adenocarcinoma cell lines established from CEA424/SV40 T antigen-transgenic mice with or without a human CEA transgene.
Nöckel J; van den Engel NK; Winter H; Hatz RA; Zimmermann W; Kammerer R
BMC Cancer; 2006 Mar; 6():57. PubMed ID: 16536871
[TBL] [Abstract][Full Text] [Related]
37. Randomized phase II/III trial of interferon Alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell Carcinoma: the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951).
Aass N; De Mulder PH; Mickisch GH; Mulders P; van Oosterom AT; van Poppel H; Fossa SD; de Prijck L; Sylvester RJ
J Clin Oncol; 2005 Jun; 23(18):4172-8. PubMed ID: 15961764
[TBL] [Abstract][Full Text] [Related]
38. Improved antibody targeting with interferon-alpha-2b conjugate.
Thakur ML; Li J; Donegan M; Pallela VR; Kolan H; Duggaraju R; Maish D; Srivastava S
J Immunother; 1997 May; 20(3):194-201. PubMed ID: 9181457
[TBL] [Abstract][Full Text] [Related]
39. Gamma-interferon enhancement of carcinoembryonic antigen expression in human colon carcinoma xenografts.
Kuhn JA; Wong JY; Beatty BG; Esteban JM; Williams LE; Beatty JD
J Immunother (1991); 1992 May; 11(4):257-66. PubMed ID: 1599911
[TBL] [Abstract][Full Text] [Related]
40. Expression of four CEA family antigens (CEA, NCA, BGP and CGM2) in normal and cancerous gastric epithelial cells: up-regulation of BGP and CGM2 in carcinomas.
Kinugasa T; Kuroki M; Takeo H; Matsuo Y; Ohshima K; Yamashita Y; Shirakusa T; Matsuoka Y
Int J Cancer; 1998 Mar; 76(1):148-53. PubMed ID: 9533775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
